Considering the different roles of CD86 in different tumors, for example, infiltration of CD86 TAMs indicates a good prognosis in colorectal cancer [18], whereas in patients with multiple myeloma, CD86 TAMs do not correlate with tumor progression [19]. The gene discussed is CD86; the disease is plasma cell myeloma.